#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

Endologix appoints Matthew Thompson as CMO

Share on Twitter Share on LinkedIn
Staff Writer | Irvine, Ca., USA | October 26, 2016
EndologixOctober 26, 2016, Irvine, Ca., USA - Endologix, a developer and marketer of treatments for aortic disorders, announced the appointment of Matthew Thompson as chief medical officer effective December 2016.
Dr. Thompson served as Professor of Vascular Surgery at St. George’s, University of London and St George’s Vascular Institute (SGVI). He trained at Cambridge, St. Bartholomew’s Hospital, the University of Leicester and Adelaide.

Dr. Thompson's awards include a Hunterian Professorship, the Moynihan travelling fellowship and the gold medal for the intercollegiate examination. He is also the editor of the Oxford Textbook of Vascular Surgery and the Oxford Handbook of Vascular Surgery.

Dr. Thompson was Chair of the National Specialized Commissioning Clinical Reference Group for Vascular Services and is a founder of the British Society for Endovascular Therapy.

Dr. Thompson is also a Council Member of the Vascular Society, Chairman of the Vascular Society Annual Scientific Meeting and elected President for 2018.